• Publications
  • Influence
Efficacy and tolerability of initial combination therapy with vildagliptin and pioglitazone compared with component monotherapy in patients with type 2 diabetes
Aim:  The aim of this study was to compare efficacy and tolerability of initial combination therapy with vildagliptin/pioglitazone to component monotherapy.
  • 254
  • 22
Comparison between vildagliptin and metformin to sustain reductions in HbA1c over 1 year in drug‐naïve patients with Type 2 diabetes
Aims  To evaluate the ability of vildagliptin and metformin to sustain reductions in HbA1c over a 1‐year treatment period in drug‐naïve patients with Type 2 diabetes (Type 2 DM).
  • 268
  • 20
The prognosis of pregnancy in women with chronic hypertension.
OBJECTIVE Our purpose was to assess pregnancy outcomes in women with chronic hypertension from a population with a perinatal mortality of 12 in 1000. STUDY DESIGN A longitudinal cohort study wasExpand
  • 259
  • 9
Systematic off-pump coronary artery revascularization in multivessel disease: experience of three hundred cases.
OBJECTIVE We sought to report our recent experience with off-pump coronary artery revascularization in multivessel disease. METHODS Between October 1996 and December 1998, 300 off-pump beatingExpand
  • 182
  • 9
Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea *
Aim:  To compare the efficacy and tolerability of vildagliptin vs. placebo in patients with type 2 diabetes mellitus (T2DM) who are inadequately controlled [haemoglobin A1c (HbA1c) 7.5 to 11%] withExpand
  • 229
  • 9
Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.
Patients with atrial fibrillation (AF) report impaired health-related quality of life (QOL). Differences between men and women with AF have not been described and personality attributes such asExpand
  • 163
  • 9
Outcome with high blood lactate levels during cardiopulmonary bypass in adult cardiac operation.
BACKGROUND High blood lactate levels during cardiopulmonary bypass (CPB) are associated with tissue hypoperfusion and may contribute to postoperative complications or death. The objective of thisExpand
  • 153
  • 9
An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database
Aim: To assess the safety of vildagliptin versus all comparators (ACs) with regard to organs, systems or tissues of particular interest in type 2 diabetes (T2DM) and areas of potential concern withExpand
  • 137
  • 7
Diastolic Dysfunction is Predictive of Difficult Weaning from Cardiopulmonary Bypass
Diastolic function is receiving more attention since echocardiographic measurements were developed and have become widely available. The importance and significance of diastolic dysfunction (DD)Expand
  • 90
  • 6
Assessing the cardio–cerebrovascular safety of vildagliptin: meta‐analysis of adjudicated events from a large Phase III type 2 diabetes population
Aim: To assess the cardiovascular and cerebrovascular (CCV) safety of the dipeptidyl peptidase‐IV inhibitor vildagliptin.
  • 166
  • 3